0001104659-17-017613.txt : 20170317 0001104659-17-017613.hdr.sgml : 20170317 20170317161753 ACCESSION NUMBER: 0001104659-17-017613 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170315 FILED AS OF DATE: 20170317 DATE AS OF CHANGE: 20170317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001660719 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 BUSINESS PHONE: 905-876-1118 MAIL ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOVEN ANDREW I CENTRAL INDEX KEY: 0001258673 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37691 FILM NUMBER: 17698210 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE, SUITE 1710 STREET 2: C/O ARALEZ PHARMACEUTICALS INC. CITY: NEW YORK STATE: NY ZIP: 10019 4 1 a4.xml 4 X0306 4 2017-03-15 0 0001660719 Aralez Pharmaceuticals Inc. ARLZ 0001258673 KOVEN ANDREW I C/O ARALEZ PHARMACEUTICALS INC., 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 ONTARIO, CANADA 0 1 0 0 President & Chief Business Off Common Shares, without par value 2017-03-15 4 P 0 20000 2.546 A 1424236 D This transaction was executed in multiple trades at prices ranging from $2.525 to $2.560. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Eric L. Trachtenberg, attorney-in-fact for Andrew I. Koven 2017-03-17